Cross-reactivity in flavivirus serology: New implications of an old finding?

Medical Microbiology and Immunology

Volumn 190, Issue 4, 2002, Pages 199-202

  Allwinn, R ^a   Doerr, H ^a   Emmerich, P ^b   Schmitz, H ^b   Preiser, W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Antibody cross reactivity; Dengue; Flavivirus; Vaccination; Yellow fever

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNOASSAY; LABORATORY TEST; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SEROLOGY; TICK BORNE ENCEPHALITIS; VACCINATION; VIRUS DETECTION; VIRUS INFECTION; YELLOW FEVER FLAVIVIRUS;

ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE VIRUS; ENCEPHALITIS VIRUSES, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; VACCINATION; YELLOW FEVER VIRUS;

EID: 0036124708     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-001-0107-9     Document Type: Article

References (28)

1. Rapid diagnosis of primary dengue fever by the immunochromatographic test and by electron microscopy - A case report
2. Arboviruses
3. Diagnosis of tick-borne encephalitis: Evaluation of sera with borderline titers with the TBE-ELISA
4. Cross reactions of patients with acute dengue fever to tick-borne encephalitis
5. Dengue fever
6. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity
7. Pathogenesis of dengue: Challenges to molecular biology
8. Correlation between ELISA, haemagglutination inhibition, and neutralisation tests after vaccination against tick-borne encephalitis
9. An enzyme linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate
10. Emerging viral pathogens in long-term expatriates (II): Dengue virus
11. Influence of rheumatoid factor on the specificity of a rapid immunochromatographic test for diagnosing dengue infection
12. Evaluation of an IgM immunoblot kit for dengue diagnosis
13. Evaluation of a capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection
14. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system
15. Studies on serological cross-reaction in sequential flavivirus infections
16. Dengue. The risk to developed and developing countries
17. Flaviviruses
18. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays; neutralisation test, haemagglutination inhibition test, immunofluorescence assay and ELISA
19. Comparison of six different commercial IgG-ELISA kits for the detection of TBEV-antibodies
20. Evaluation of the MRL Diagnostics dengue fever virus IgM capture ELISA and the PanBio rapid immunochromatographic test for the diagnosis of dengue fever in Jamaica
21. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas
22. Persistence of neutralizing antibody to yellow fever virus 30 to 35 years following immunization with the 17D yellow fever vaccine: A study of World War II veterans in 1975-1976
23. Clinical evaluation of a rapid immunochromatographic test for the diagnosis of dengue virus infection
24. Dengue-Fieber
25. Imported tropical virus infections in Germany
26. Evaluation of ELISA-based sero-diagnosis of dengue fever in travellers
27. Travel-related vector-borne virus infections in Germany
28. Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection